- Features of ARTES´ Hansenula polymorpha protein production
platform – Production of holoproteins containing a co-factor and/or prosthetic group in Hansenula polymorpha.
Read more in our white paper Heterologous Production of Holoproteins in Hansenula polymorpha - Efficient production of secreted and active Invertase – highly active Invertase expressed in Hansenula polymorpha.
Read more in our white paper Efficient Production of Secreted and Active Invertase
METAVAX® our proprietary platform to develop highly immunogenic chimeric VLP-based vaccines presenting customer’s antigen target. Our platform is built on the WHO recommended production host Hansenula polymorpha and our unique duck hepatitis B virus like particle (dHBs).
ARTES continuously develops valuable biosimilar processes. All of them excel with safe, fast and ef cient production features. Our cell lines and processes provide lower cost-of-goods and higher stability than originator and competitor processes. ARTES’ experienced technology transfer team is dedicated to support you for smooth implementation at your manufacturing site.
ARTES is a well-established R&D partner for the pharmaceutical industry. Our technology and know-how is secured by own IP, exclusive licenses and trade secrets. Our cell line development is based on efficient high-yield microbial expression platforms. Several recombinant products derived from our platforms are marketed worldwide by our clients.
Click here to add your own text